Michael Duran, PA
Pain Medicine · High Point, NCNPI 1275568099
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.9% of the total across 434 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 30 manufacturers, the largest accounting for just 17.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $2,717 and has fallen 90.8% since, to $249 in 2024.
Across 434 payments — averaging $15.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Novo Nordisk$619
- Lilly USA, LLC$462
- Merck$419
- Johnson & Johnson$370
- Amarin Pharma, Inc.$352
- plus $3K from 24 others
What the payments were for
- Food & beverage$6,768100%
- Education$40%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 82 | $1,169 |
| Novo Nordisk | 43 | $619 |
| Lilly USA, LLC | 31 | $462 |
| Merck | 26 | $419 |
| Johnson & Johnson | 26 | $370 |
| Amarin Pharma, Inc. | 23 | $352 |
| Amgen | 23 | $352 |
| AstraZeneca | 21 | $347 |
| Boehringer Ingelheim | 18 | $259 |
| Forte Bio-pharma LLC | 4 | $221 |
| GSK | 12 | $194 |
| Daiichi Sankyo Inc. | 10 | $189 |
| Bayer | 19 | $186 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $183 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 12 | $179 |
| Pfizer | 11 | $158 |
| Heartflow, Inc. | 1 | $148 |
| Kowa Pharmaceuticals America, Inc. | 13 | $146 |
| Biohaven Pharmaceutical Holding Company Ltd. | 12 | $140 |
| Novartis | 9 | $131 |
| Sanofi-aventis U.S. LLC | 1 | $123 |
| E.r. Squibb & Sons, L.L.C. | 5 | $91 |
| Biohaven Pharmaceuticals, Inc. | 5 | $89 |
| Baxter Healthcare | 3 | $54 |
| Xeris Pharmaceuticals, Inc. | 3 | $48 |
| Arcutis Biotherapeutics, Inc. | 3 | $44 |
| Teva Pharmaceuticals USA, Inc. | 2 | $33 |
| Ironwood Pharmaceuticals, Inc | 2 | $28 |
| Supernus Pharmaceuticals, Inc. | 1 | $23 |
| Esperion Therapeutics, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FFRct$148
How this compares
$6,772 in reported general payments places this provider in the 60th percentile of 182 pain medicine providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 17 | $16,698 |
| Repatha SureclickEvolocumab | 11 | $12,953 |
| Tresiba Flextouch U-100Insulin Degludec | 12 | $5,959 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 14 | $601 |
| Trazodone Hcl | 23 | $318 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 12 | $313 |
| Pregabalin | 12 | $272 |
| Omeprazole | 19 | $263 |
| Metoprolol Succinate | 22 | $226 |
| Amlodipine Besylate | 60 | $225 |
| Atorvastatin Calcium | 35 | $222 |
| Simvastatin | 14 | $198 |
| Gabapentin | 20 | $196 |
| Pravastatin Sodium | 20 | $188 |
| Cyclobenzaprine Hcl | 11 | $154 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in High Point
- Janus PatelHigh Point$12K
- Oscar FlorendoHigh Point$9K
- Amanda TaylorHigh Point$8K
- James NorthWinston Salem$721K
- Leonardo KapuralWinston Salem$523K
- Christopher GilmoreWinston Salem$457K
- Richard RauckWinston Salem$431K
- Courtney AumanJacksonville$186K
- Jacob WangCharlotte$162K
- Aashish KumarCharlotte$160K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.